Tempo Therapeutics has filed a notice of an exempt offering of securities to raise $16,793,660.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Tempo Therapeutics is raising up to $16,793,660.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Westbrook Weaver played a…
